20 mg Peptide Strength
Each vial contains a labeled strength of 20 mg of Livagen.
Dragon Pharma
You will save $46.00
Livagen 20 mg
Gene Expression/Liver Research Peptide
- Product: Livagen 20 mg
- Active Substance: Livagen
- Strength: 20 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$69.00
$115.00
Warehouse :
International
U.S. Domestic
Out of stock
- Overview
- Science & Research
- Safety Information
- FAQ
- Reviews
Dragon Pharma Peptide Product
Dragon Pharma Livagen 20 mg Overview
Dragon Pharma Livagen is supplied as a lyophilized powder in a 2 mL vial and contains the synthetic peptide Livagen at a labeled strength of 20 mg. Product specifications, storage information, and available payment options are provided below.
Lyophilized Powder Form
Supplied as a freeze-dried powder that requires reconstitution with bacteriostatic water before use.
2 mL Vial
Packaged in a standard 2 mL peptide vial with a rubber stopper and aluminum seal.
Gene Expression Research
Livagen has been investigated in preclinical research for its potential effects on gene expression and related physiological processes.
Product Specifications
| Product name | Livagen 20 mg |
|---|---|
| Active substance | Livagen |
| Labeled strength | 20 mg/vial |
| Container | 2 mL vial |
| Total labeled content | 20 mg per vial |
| Product form | Lyophilized powder |
| Manufacturer | Dragon Pharma |
Related Peptide Options
Other peptide options from the same product line include Epitalon 50 mg, another peptide investigated for its potential effects on cellular processes, and AOD-9604 5 mg, a peptide fragment investigated for metabolic research. These products differ in their peptide structure and research applications.
Science & Research
Understanding Livagen
Livagen is a synthetic peptide that has been investigated in preclinical research for its potential effects on gene expression and related physiological processes. This section provides a brief overview of what is known about this peptide from research literature.
Synthetic Peptide
Livagen is a synthetic peptide that has been studied in research settings for its potential effects on gene expression and cellular processes. Its structure is designed for specific biological activity in research applications.
Research Applications
Preclinical research has investigated Livagen for its potential effects on gene expression and related physiological processes. The peptide has been studied in laboratory settings for its interactions with cellular pathways.
Mechanism of Action
The precise mechanism of action of Livagen is not fully characterized. Research suggests it may influence gene expression and cellular function, though the exact molecular targets remain an area of ongoing investigation.
Peptide Reconstitution and Use
This product is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water or sterile water for injection before use. The addition of water converts the freeze-dried powder into a solution suitable for research applications.
The reconstituted peptide solution should be stored as recommended on the product label. Peptide solutions are typically refrigerated and used within a specified timeframe after reconstitution to maintain integrity.
Research References
Peer-reviewed research on Livagen is available through the National Institutes of Health and other scientific databases. The following link provides general information on this peptide and its mechanism of action.
Important Health Information
Livagen 20 mg Safety Information
Peptide research compounds such as Livagen have limited clinical safety data. The information below is derived from published preclinical research and general knowledge of peptide biology and does not constitute medical advice.
Limited Clinical Data
Livagen has not been extensively studied in humans. The available safety information comes primarily from preclinical research.
Gene Expression Effects Unknown
The full range of effects of Livagen on gene expression and cellular function is not fully characterized. The significance of its interactions with cellular pathways is not completely understood.
Injection-Related Risks
Subcutaneous injection carries risks including injection-site reactions, infection and improper technique. Sterile handling and correct reconstitution procedures are essential.
Systemic Effects Unknown
The potential systemic effects of Livagen and its interactions with other physiological systems are not fully understood.
Contraindications
This peptide research compound should not be used by individuals with known allergies or sensitivities to peptide compounds, or by those who are pregnant, nursing or have active malignancies.
Limited Research
The long-term effects and safety profile of Livagen have not been established in any population. Research on this peptide is still in the early stages.
Conditions That Require Medical Review
Medical advice is particularly important for individuals with liver conditions, cancer or a history of cancer, autoimmune conditions, cardiovascular disease, or those taking medications that affect gene expression or cellular function. This peptide should not be used during pregnancy or breastfeeding.
The product should also be stored securely to prevent accidental access or use by children or other household members, particularly after reconstitution when it contains a liquid solution.
Tested Sport
Livagen is not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change. Some peptide compounds may fall under general prohibitions on substances with similar biological effects.
The current status and applicable rules can be checked through the World Anti-Doping Agency Prohibited List.
Common Product Questions
Dragon Pharma Livagen 20 mg FAQ
Quick answers about Livagen 20 mg specifications, storage, shipping, Bitcoin payment and general product information.
What is Dragon Pharma Livagen 20 mg?
Dragon Pharma Livagen 20 mg is a lyophilized peptide product containing 20 mg of Livagen per vial. It is supplied in a 2 mL vial for research purposes.
What is Livagen?
Livagen is a synthetic peptide that has been investigated in preclinical research for its potential effects on gene expression and related physiological processes.
How much peptide is in each vial?
Each vial contains a labeled strength of 20 mg of Livagen.
How is the product supplied?
The product is supplied as a lyophilized powder in a 2 mL vial. It requires reconstitution with bacteriostatic water or sterile water for injection before use.
How should Livagen be stored?
Store the lyophilized powder in its original packaging at room temperature or refrigerated, protected from excessive heat, moisture and direct light. Once reconstituted, peptide solutions typically require refrigeration and should be used within a limited timeframe. Always follow the specific storage directions printed on the product label.
Does Livagen require refrigeration?
Lyophilized peptide powders are generally stable at room temperature but should be protected from heat. After reconstitution, peptide solutions typically require refrigeration. Check the product label for specific storage instructions.
How long does Livagen delivery take?
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Can I buy Livagen with Bitcoin?
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy Livagen 20 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Is Bitcoin payment anonymous?
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
Is Livagen permitted in tested sport?
Livagen is not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change.
Where can I find more information on Livagen?
Additional research on this peptide is available through the National Institutes of Health and other scientific databases. A direct link to PubMed references is provided in the Science & Research section above.
Related Offers
Lab Tested
Domestic & International
NEW
-40% OFF
Dragon Pharma, Europe
Copper Peptide / Tissue Research
- Product: GHK-CU 50 mg
- Active Substance: GHK-CU
- Strength: 50 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$27.00
$45.00
NEW
Shipped USA Domestic
-40% OFF
Dragon Pharma, Europe
AMPK Activator Research Compound
- Product: AICAR 50 mg
- Active Substance: AICAR
- Strength: 50 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$63.00
$105.00